First Tracks Biotherapeutics, Inc. (TRAX)
Market Closed
30 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XDUS $
47. 78
+5.91
+14.1151%
$
1.24B Market Cap
- P/E Ratio
- Div Yield
970,058 Volume
- Eps
$ 41.87
Previous Close 
Want to track TRAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
First Tracks Biotherapeutics, Inc. (TRAX) Statistics
Valuation metrics
Market Cap 1.24B
Enterprise value 990.91M
Trailing P/E (ttm) -12.64
Forward P/E -
PEG ratio -0.13
Price/Sales (ttm) -
Price/Book (mrq) 4.79
Enterprise Value/Revenue -
Enterprise Value/EBITDA -9.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 483.3K
Average volume (90 days) 491.53K
Price summary
52-Week low 14.72
52-Week high 47.99
Beta -
50-Day moving average 18.97
200-Day moving average 17.73
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.34%
Return on equity -0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.81
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.24
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 8.74%
Book value per share (mrq) 7.41
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
